AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2016

May 13, 2016

32093_dirs_2016-05-13_6a4067c1-e48c-4242-91e5-d8225315ebce.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2016-05-13

Reporting Person: LEVANDE ROBERT (Director, Chairman of the Board)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	168750	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$2.67	2020-02-01	Common Stock (75655)		Direct
Warrants (right to buy)	$2.67	2021-11-06	Common Stock (45638)		Direct

Footnotes

F1: The shares subject to the option will vest in equal quarterly installments over a three year period that commenced on May 1, 2015 and will end on February 1, 2018, subject to the Reporting Person's continued service through each vesting date.

F2: Subject to adjustment as set forth in the warrant.